<DOC>
	<DOCNO>NCT00252434</DOCNO>
	<brief_summary>The purpose study evaluate whether specially develop group counsel approach well able help HIV-positive gay bisexual men ( GBM ) use crystal meth stop use methamphetamine , reduce sexual risk behavior , stay HIV medication standard drug treatment program . Another purpose determine whether drug abuse treatment program HIV medical clinic make easy attend treatment go separate location drug abuse treatment .</brief_summary>
	<brief_title>Behavioral Therapy Development Methamphetamine Abuse</brief_title>
	<detailed_description>The study feature activity include development refinement culturally-specific cognitive behavioral therapy integrate aspect drug abuse treatment HIV medication adherence intervention cultural element gay bisexual man receive medical care HIV/AIDS . To estimate size signal intervention , study proposes two parallel group design 50 treatment-seeking HIV-seropositive gay bisexual men meet criterion methamphetamine abuse receive HIV medical care UCLA Center Clinical AIDS Research Education ( CARE ) clinic randomize study condition treatment-as-usual ( TAU ) condition . Participants assign experimental condition receive 12 week twice-weekly GCBT , 6-months post-randomization follow-up visit . Participants assign TAU condition refer UCLA Addiction Medicine Clinic ( AMC ) , receive clinic 's standard care treatment methamphetamine dependence 12 week , return 6-month follow-up visit . Analyses conduct participant meet inclusion/exclusion criterion , express desire treatment , receive least one `` dose '' cognitive-behavioral treatment make one visit AMC . Participants condition agree weekly monthly data collection visit , include provision urine sample . Primary outcome variable methamphetamine use , sexual risk behavior , HIV medication compliance . The propose design maintain focus intervention development feasibility , recognize second phase development inform accurate estimate effect size intervention adequate resource conduct full-scale trial .</detailed_description>
	<mesh_term>Sexually Transmitted Diseases</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>1 . HIVseropositive , GBM receive medical treatment HIV least 30 day prior sign inform consent University California , Los Angeles ( UCLA ) Center Clinical AIDS Research Education ( CARE ) clinic , age 1865 2 . Willing give inform consent comply study procedures 3 . Willing provide consent contact treat physician pharmacy assess adherence HIV medication 4 . Diagnosed current methamphetamine abuse determine MiniInternational Neuropsychiatric Interview ( MINI ) 5 . Interested seek treatment methamphetamine abuse participate research project . 1 . Unwilling give , withdrawal , inform consent 2 . Inability understand nature study 3 . A psychiatric condition , principal investigator 's judgment , warrant additional intervention ensure participant safety ( e.g. , meet Diagnostic Statistical Manual Mental Disorders , 4th Edition , Text Revision [ DSMIVTR ] criterion current bipolar disorder psychotic disorder ) 4 . Current suicidal ideation suicide attempt within past 3 month 5 . Concurrent dependence opiate , alcohol , benzodiazepine determine MINI . 6 . Total lack type healthcare coverage . These potential participant give lowfee treatment referral .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>high-risk sexual behavior</keyword>
	<keyword>methamphetamine use</keyword>
	<keyword>drug craving</keyword>
	<keyword>addiction behavior</keyword>
</DOC>